The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - AstraZeneca; Lilly; Novartis; Pfizer; Roche
A phase 3 study of alpelisib (ALP) plus fulvestrant (FUL) in men and postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) ABC progressing on or after aromatase inhibitor (AI) therapy: SOLAR-1.
 
Hope S. Rugo
Honoraria - Genomic Health
Consulting or Advisory Role - Amgen
Speakers' Bureau - Genomic Health
Research Funding - Eisai (Inst); Genentech (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Bayer; Novartis; OBI Pharma; Pfizer; Roche/Genentech
 
Fabrice Andre
No Relationships to Disclose
 
Gabor Rubovszky
Research Funding - Hospira (Inst); Novartis (Inst)
 
Bella Kaufman
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer
Speakers' Bureau - Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Kenichi Inoue
Research Funding - Novartis (Inst)
 
Masato Takahashi
No Relationships to Disclose
 
Satoru Shimizu
No Relationships to Disclose
 
Eva M. Ciruelos
No Relationships to Disclose
 
Mario Campone
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
Speakers' Bureau - Novartis
Research Funding - Novartis
 
Pier Franco Conte
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Roche/Genentech
Research Funding - Merck Serono (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; celgene; Novartis
 
Hiroji Iwata
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis; Novartis (Inst)
 
Sibylle Loibl
No Relationships to Disclose
 
Ingrid A. Mayer
Consulting or Advisory Role - AstraZeneca; Novartis
Research Funding - Novartis; Pfizer
 
Dejan Juric
Consulting or Advisory Role - Eisai; EMD Serono; Novartis
 
Anne-Sophie Longin
Employment - Novartis; Novartis
 
David Mills
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Patents, Royalties, Other Intellectual Property - Novartis
 
Celine Wilke
Employment - Novartis
 
Dalila B. Sellami
Employment - Actelion (I); Novartis
Stock and Other Ownership Interests - Actelion (I); Novartis
Honoraria - Novartis
Patents, Royalties, Other Intellectual Property - Novartis